文献速递头颈部肿瘤放疗放疗物理与技术

头颈部肿瘤危及器官勾画的观察者间变异研究

Interobserver variability in organ at risk delineation in head and neck cancer.
PubMed 文献 · Radiat Oncol · 2021-06-28

该研究邀请比利时各放疗中心头颈肿瘤放疗医生对5例头颈肿瘤病例进行危及器官勾画,并以基于国际共识指南训练的人工智能工具生成的参考轮廓为对照,评估指南存在下的观察者间变异。结果显示颌骨、脑干、颌下腺和腮腺勾画一致性较好,口腔、耳蜗、咽缩肌、声门上喉和声门区变异较大;使用共识指南者观察者间变异显著更低(p=0.008)。

要点

  • 使用国际共识指南的放疗医生观察者间变异显著更低(p=0.008)。
  • 颌骨、脑干、颌下腺和腮腺勾画与参考轮廓一致性较好。
  • 口腔、耳蜗、咽缩肌、声门上喉和声门区勾画变异较大。

核心结论

  • 头颈肿瘤危及器官勾画国际共识指南仅约半数参与医生实施,部分解释勾画变异,但指南本身不足以消除观察者间变异。

研究设计与样本

  • 邀请比利时各放疗中心头颈肿瘤放疗医生完成问卷并为5例头颈肿瘤病例提交危及器官勾画。
  • 参考轮廓由基于国际共识指南训练的临床验证人工智能工具生成。
  • 采用Dice相似系数、平均表面距离和95% Hausdorff距离进行比较。

主要发现

  • 颌骨与参考轮廓一致性最佳:中位DSC 0.9(范围0.8-0.9),中位MSD 1.1 mm(范围0.8-8.3),中位HD95 3.4 mm(范围1.5-38.7)。
  • 脑干:中位DSC 0.9(范围0.6-0.9),中位MSD 1.5 mm(范围1.1-4.0),中位HD95 4.0 mm(范围2.3-15.0)。
  • 颌下腺:中位DSC 0.8(范围0.5-0.9),中位MSD 1.2 mm(范围0.9-2.5),中位HD95 3.1 mm(范围1.8-12.2)。

临床怎么用

  • 头颈肿瘤放疗中应推动国际共识指南的实施以减少危及器官勾画变异。
  • 对口腔、耳蜗、咽缩肌、声门上喉和声门区等变异较大部位需额外质控或标准化措施。
  • 可借助人工智能等工具辅助勾画以促进治疗标准化。

局限性

  • 参考轮廓由人工智能工具生成而非专家人工勾画金标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In radiotherapy inaccuracy in organ at risk (OAR) delineation can impact treatment plan optimisation and treatment plan evaluation. Brouwer et al. showed significant interobserver variability (IOV) in OAR delineation in head and neck cancer (HNC) and published international consensus guidelines (ICG) for OAR delineation in 2015. The aim of our study was to evaluate IOV in the presence of these guidelines. METHODS: HNC radiation oncologists (RO) from each Belgian radiotherapy centre were invited to complete a survey and submit contours for 5 HNC cases. Reference contours (OARref) were obtained by a clinically validated artificial intelligence-tool trained using ICG. Dice similarity coefficients (DSC), mean surface distance (MSD) and 95% Hausdorff distances (HD95) were used for comparison. RESULTS: Fourteen of twenty-two RO (64%) completed the survey and submitted delineations. Thirteen (93%) confirmed the use of delineation guidelines, of which six (43%) used the ICG. The OARs whose delineations agreed best with the OARref were mandible [median DSC 0.9, range (0.8-0.9); median MSD 1.1 mm, range (0.8-8.3), median HD95 3.4 mm, range (1.5-38.7)], brainstem [median DSC 0.9 (0.6-0.9); median MSD 1.5 mm (1.1-4.0), median HD95 4.0 mm (2.3-15.0)], submandibular glands [median DSC 0.8 (0.5-0.9); median MSD 1.2 mm (0.9-2.5), median HD95 3.1 mm (1.8-12.2)] and parotids [median DSC 0.9 (0.6-0.9); median MSD 1.9 mm (1.2-4.2), median HD95 5.1 mm (3.1-19.2)]. Oral cavity, cochleas, PCMs, supraglottic larynx and glottic area showed more variation. RO who used the consensus guidelines showed significantly less IOV (p = 0.008). CONCLUSIONS: Although ICG for delineation of OARs in HNC exist, they are only implemented by about half of RO participating in this study, which partly explains the delineation variability. However, this study highlights that guidelines alone do not suffice to eliminate IOV and that more effort needs to be done to accomplish further treatment standardisation, for example with artificial intelligence.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. van der Veen J, Gulyban A, Willems S, et al. Interobserver variability in organ at risk delineation in head and neck cancer. Radiat Oncol. 2021. PMID: 34183040. doi:10.1186/s13014-020-01677-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。